… Ridgeback 公司合作开发的第3款治疗COVID-19新药:莫努匹韦(molnupiravir)胶囊上市ꎬ商品名 lagevrio … Molnupiravir for oraltreatment of Covid-19 in nonhospitalizedpatients[J].N Engl J …
… 非住院COVID-19 成年患者,试验 最终表明:对于有症状的COVID-19 非… for treatment of non-hospitalizedpatients with COVID-19:a … Molnupiravir plus usual care versus usual care alone …
… to in⁃ clude the treatment of COVID-19 in non-hospitalized adults and pediatric patients(12 … 用礼来公司的单抗Bebtelovimab 或默沙东公司的 Molnupiravir;②对重症患者,优先推荐使用瑞德…
… 继辉瑞公司的奈玛特韦/ 利托那韦和默沙东的molnupiravir 在国 … versus nirmatrelvir-ritonavir for oraltreatment of COVID-19[J]. … regulatory alignment on COVID-19 medicines and vaccines[…
… Oral nirma⁃ trelvir for high-risk,nonhospitalized adults with … be⁃ tween common dermatological medications and the oral antiCOVID-19 agents nirmatrelvir-ritonavir and molnupiravir[J]. …
… the effect of such patients. Methods 92 inpatients of COVID-19treated with Paxlovid in three … Combined predictors could be calculated by the above risk factors before medication. The …